Dermatologic adverse events associated with Juvenile Idiopathic Arthritis treatment

Risultato della ricerca: Posterpeer review

Abstract

Introduction: Steroids and disease-modifying anti-rheumatic drugs (DMARDs) are widely used in the treatment of juvenile idiopathic arthritis (JIA). Dermatologic adverse events including psoriasis have been reported in treatment of various inflammatory diseases (1-3). However, data regarding the occurrence of dermatologic adverse events in JIA patients are scarce (4-6).Objectives: To determine the prevalence of dermatologic adverse events in JIA patients treated with systemic steroids and DMARDs. To investigate an association between drugs and dermatologic adverse events and the association between anti-TNF treatment and psoriasiform lesions.
Lingua originaleEnglish
Pagine110-110
Numero di pagine1
Stato di pubblicazionePublished - 2020

Fingerprint

Entra nei temi di ricerca di 'Dermatologic adverse events associated with Juvenile Idiopathic Arthritis treatment'. Insieme formano una fingerprint unica.

Cita questo